يعرض 1 - 16 نتائج من 16 نتيجة بحث عن '"Proteasome Inhibitors/pharmacology"', وقت الاستعلام: 0.82s تنقيح النتائج
  1. 1
    Academic Journal

    المصدر: Diaz-delCastillo , M , Gundesen , M T , Andersen , C W , Nielsen , A L , Møller , H E H , Vinholt , P J , Asmussen , J T , Kristensen , I B , Nyvold , C G , Abildgaard , N , Levin Andersen , T & Lund , T 2023 , ' Increased Bone Volume by Ixazomib in Multiple Myeloma : 3-Month Results from an Open Label Phase 2 Study ' , Journal of Bone and Mineral Research , vol. 38 , no. 5 , pp. 639-649 . https://doi.org/10.1002/jbmr.4807

    وصف الملف: application/pdf

  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
  5. 5
    Academic Journal

    المساهمون: Institut de pharmacologie et de biologie structurale (IPBS), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS), The work was supported in part by grants from the Région Midi‐Pyrénées, the “Fondation pour la Recherche Médicale” (programme Grands Equipements), European Fonds (FEDER), Toulouse metropole, “Fond Social Européen” (FSE) and the “Ligue contre le cancer” Grants., We thank Dr. Darragh O'Brien from Institut Pasteur for the careful reading of this manuscript., We thank members of the group for insightful comments related to this work. We would like to thank David Bouyssié for MFPAQ software and technical support. We would like also to thank our collaborators Stephane Manenti, for discussion. We Thanks Pr. Dr. Ruedi Aebersold from IMSB (ETH Zurich) for allowing the SRM measurement on the TSQ Vantage.

    المصدر: ISSN: 1615-9853.

  6. 6
    Academic Journal
  7. 7
    Academic Journal

    المساهمون: European T-cell Lymphoma Study Group, Abele, C., Bessone, L., Barreca, A., Boi, M., Cavallo, F., Chiesa, N., Crescenzo, R., Fienga, A., Gaudiano, M., di Giacomo, F., Inghirami, G., Landra, I., Lasorsa, E., Marchiorlatti, R., Martinoglio, B., Medico, E., Ferrero, GB., Messana, K., Mereu, E., Pellegrino, E., Piva, R., Scafò, I., Spaccarotella, E., Tabbò, F., Todaro, M., Ubezzi, I., Urigu, S., Novero, D., Chiapella, A., Vitolo, U., Abate, F., Ficarra, E., Acquaviva, A., Agnelli, L., Neri, A., Chilosi£££Anna Caliò Marco£££ AC., Zamó, A., Facchetti, F., Lonardi, S., De Chiara, A., Fulciniti, F., Ferreri, A., Ponzoni, M., Agostinelli, C., Piccaluga, PP., Pileri, S., Falini, B., Tiacci, E., Van Loo, P., Tousseyn, T., De Wolf-Peeters, C., Geissinger, E., Muller-Hermelink, HK., Rosenwald, A., Piris, MA., Rodriguez, ME., Bertoni, F., Rinaldi, A., Kwee, I., Chiattone, C., Paes, RA.

    المصدر: Leukemia, vol. 29, no. 6, pp. 1390-1401

    وصف الملف: application/pdf

    Relation: info:eu-repo/semantics/altIdentifier/pmid/25533804; info:eu-repo/semantics/altIdentifier/eissn/1476-5551; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_0D92E89F5C271; https://serval.unil.ch/notice/serval:BIB_0D92E89F5C27; https://serval.unil.ch/resource/serval:BIB_0D92E89F5C27.P001/REF.pdf

  8. 8

    المساهمون: Hematology, Basic (bio-) Medical Sciences

  9. 9
    Academic Journal
  10. 10

    المساهمون: Institut de pharmacologie et de biologie structurale (IPBS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, The work was supported in part by grants from the Région Midi‐Pyrénées, the 'Fondation pour la Recherche Médicale' (programme Grands Equipements), European Fonds (FEDER), Toulouse metropole, 'Fond Social Européen' (FSE) and the 'Ligue contre le cancer' Grants., We thank Dr. Darragh O'Brien from Institut Pasteur for the careful reading of this manuscript., We thank members of the group for insightful comments related to this work. We would like to thank David Bouyssié for MFPAQ software and technical support. We would like also to thank our collaborators Stephane Manenti, for discussion. We Thanks Pr. Dr. Ruedi Aebersold from IMSB (ETH Zurich) for allowing the SRM measurement on the TSQ Vantage., Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Proteomics
    Proteomics, Wiley-VCH Verlag, 2017, Applications and Developments in Targeted Proteomics, 17 (7), pp.1600089. ⟨10.1002/pmic.201600089⟩

    مصطلحات موضوعية: 0301 basic medicine, MESH: Gene Ontology, Technology, Leupeptins, Cellular differentiation, Cell Cycle Proteins, Apoptosis, MESH: Cell Cycle / drug effects, Biochemistry, SILAC, MESH: Interleukins / metabolism, Bortezomib, MESH: Leukocytes / drug effects, Leukocytes, MESH: Interleukins / genetics, MESH: Apoptosis Regulatory Proteins / metabolism, Protein Isoforms, Proteasome inhibitor, Phosphorylation, MESH: Proteasome Endopeptidase Complex / drug effects, Targeted proteomics, Heat-Shock Proteins, MESH: Proteasome Endopeptidase Complex / metabolism, MESH: Computational Biology, Chemistry, Gene Expression Regulation, Leukemic, Cell Cycle, MESH: Apoptosis / drug effects, Cell Differentiation, Cell cycle, MESH: Phosphorylation / drug effects, MESH: Cell Cycle Proteins / metabolism, 3. Good health, Cell biology, MESH: Cell Cycle Proteins / genetics, MESH: Heat-Shock Proteins / genetics, Proteasome Inhibitors, medicine.drug, Research Article, Signal Transduction, MESH: Cell Differentiation, Proteasome Endopeptidase Complex, MESH: Cell Line, Tumor, Quantitative proteomics, MESH: Tumor Suppressor Protein p53 / metabolism, MESH: Protein Isoforms / genetics, MESH: Acetylcysteine / pharmacology, MESH: Molecular Sequence Annotation, MESH: Apoptosis Regulatory Proteins / genetics, MESH: Transcription Factors / genetics, MESH: Protein Isoforms / metabolism, 03 medical and health sciences, MESH: Gene Expression Profiling, MESH: Leukocytes / pathology, Heat shock protein, Cell Line, Tumor, medicine, MESH: Acetylcysteine / analogs & derivatives, Humans, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, Cell Cycle Protein, Molecular Biology, MESH: Proteasome Inhibitors / pharmacology, MESH: Transcription Factors / metabolism, MESH: Humans, MESH: Leupeptins / pharmacology, Gene Expression Profiling, Interleukins, Computational Biology, Molecular Sequence Annotation, MESH: Bortezomib / pharmacology, MESH: Tumor Suppressor Protein p53 / genetics, MESH: Heat-Shock Proteins / metabolism, MESH: Leukocytes / metabolism, Acetylcysteine, 030104 developmental biology, Gene Ontology, Proteasome, MESH: Gene Expression Regulation, Leukemic / drug effects, Tumor Suppressor Protein p53, Apoptosis Regulatory Proteins, Human acute myeloid leukemia (AML) cells, Transcription Factors

  11. 11

    المساهمون: Compartimentation et trafic intracellulaire des mRNP = Compartmentation and intracellular traffic of mRNPs (LBD-E14), Laboratoire de Biologie du Développement (LBD), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut de Biologie Paris Seine (IBPS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut de Biologie Paris Seine (IBPS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS), Erasmus exchange program, University of Naples (Naples, Italy), Funding Program for Next Generation World-Leading Researchers of the Japan Society for the Promotion of Science, New Energy and Industrial Technology Development Organization, Takeda Science Foundation, National Health and Medical Research Council of Australia, Medical Research Foundation of Royal Perth Hospital, Centre National de la Recherche Scientifique, Association pour la Recherche sur le Cancer, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut de Biologie Paris Seine (IBPS), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Molecular Biology of the Cell
    Molecular Biology of the Cell, American Society for Cell Biology, 2014, 25 (1), pp.169-183. ⟨10.1091/mbc.E13-09-0558⟩
    Molecular Biology of the Cell, 2014, 25 (1), pp.169-183. ⟨10.1091/mbc.E13-09-0558⟩

    وصف الملف: application/pdf

  12. 12

    المصدر: Molecular and Cellular Endocrinology, Vol. 367, No 1-2 (2013) pp. 1-10

  13. 13
  14. 14
    Academic Journal
  15. 15

    المساهمون: Abate, F., Todaro, M., Van Der Krogt, J.-A., Boi, M., Landra, I., Machiorlatti, R., Tabbò, F., Messana, K., Abele, C., Barreca, A., Novero, D., Gaudiano, M., Aliberti, S., Di Giacomo, F., Tousseyn, T., Lasorsa, E., Crescenzo, R., Bessone, L., Ficarra, E., Acquaviva, A., Rinaldi, A., Ponzoni, M., Longo, D.L., Aime, S., Cheng, M., Ruggeri, B., Piccaluga, P.P., Pileri, S., Tiacci, E., Falini, B., Pera-Gresely, B., Cerchietti, L., Iqbal, J., Chan, W.C., Shultz, L.D., Kwee, I., Piva, R., Wlodarska, I., Rabadan, R., Bertoni, F., Inghirami, G., The European T-cell Lymphoma Study Group [.., Agostinelli, C., ], European T-cell Lymphoma Study Group, Cavallo, F., Chiesa, N., Fienga, A., di Giacomo, F., Marchiorlatti, R., Martinoglio, B., Medico, E., Ferrero, GB., Mereu, E., Pellegrino, E., Scafò, I., Spaccarotella, E., Ubezzi, I., Urigu, S., Chiapella, A., Vitolo, U., Agnelli, L., Neri, A., Chilosi£££Anna Caliò Marco£££ AC., Zamó, A., Facchetti, F., Lonardi, S., De Chiara, A., Fulciniti, F., Ferreri, A., Piccaluga, PP., Van Loo, P., De Wolf-Peeters, C., Geissinger, E., Muller-Hermelink, HK., Rosenwald, A., Piris, MA., Rodriguez, ME., Chiattone, C., Paes, RA., Abate, F, Todaro, M, van der Krogt, Ja, Boi, M, Landra, I, Machiorlatti, R, Tabbò, F, Messana, K, Abele, C, Barreca, A, Novero, D, Gaudiano, M, Aliberti, S, Di Giacomo, F, Tousseyn, T, Lasorsa, E, Crescenzo, R, Bessone, L, Ficarra, E, Acquaviva, A, Rinaldi, A, Ponzoni, M, Longo, Dl, Aime, S, Cheng, M, Ruggeri, B, Piccaluga, Pp, Pileri, S, Tiacci, E, Falini, B, Pera-Gresely, B, Cerchietti, L, Iqbal, J, Chan, Wc, Shultz, Ld, Kwee, I, Piva, R, Wlodarska, I, Rabadan, R, Bertoni, F, Inghirami, G, andThe European T-cell Lymphoma Study, Group

    المصدر: Leukemia, vol. 29, no. 6, pp. 1390-1401

    مصطلحات موضوعية: Pathology, Cancer Research, Lymphoma, TRAF1, Messenger, Drug Resistance, Translocation, Genetic, Fusion gene, Mice, Mice, Inbred NOD, hemic and lymphatic diseases, Tumor Cells, Cultured, Anaplastic lymphoma kinase, Anaplastic, Anaplastic Lymphoma Kinase, Anaplastic large-cell lymphoma, Animals, Blotting, Western, Flow Cytometry, Gene Expression Profiling, High-Throughput Nucleotide Sequencing, Humans, Immunoprecipitation, In Situ Hybridization, Fluorescence, Lymphoma, Large-Cell, Anaplastic, NF-kappa B, Proteasome Inhibitors, Proto-Oncogene Proteins c-myc, RNA, Messenger, Real-Time Polymerase Chain Reaction, Receptor Protein-Tyrosine Kinases, Repressor Proteins, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, TNF Receptor-Associated Factor 1, Tumor Suppressor Protein p53, Xenograft Model Antitumor Assays, Drug Resistance, Neoplasm, In Situ Hybridization, Hematology, Cultured, Blotting, Medicine (all), Large-Cell, Tumor Cells, Proteasome Inhibitor, Receptor Protein-Tyrosine Kinase, Oncology, Western, Human, medicine.medical_specialty, fusion detection tool, Xenograft Model Antitumor Assay, medicine.drug_class, Translocation, Anesthesiology and Pain Medicine, Biology, anaplastic large-cell lymphomas (ALCL), RNA-Seq data, Fluorescence, Article, Genetic, Internal medicine, PRDM1, medicine, traslocation, Animal, Repressor Protein, medicine.disease, ALK inhibitor, anaplastic lymphoma kinase (ALK), Cancer research, Inbred NOD, RNA, Neoplasm, Positive Regulatory Domain I-Binding Factor 1, Lymphoma, Large-Cell, Anaplastic/drug therapy, Lymphoma, Large-Cell, Anaplastic/genetics, NF-kappa B/genetics, NF-kappa B/metabolism, Proteasome Inhibitors/pharmacology, Proto-Oncogene Proteins c-myc/genetics, Proto-Oncogene Proteins c-myc/metabolism, RNA, Messenger/genetics, Receptor Protein-Tyrosine Kinases/genetics, Receptor Protein-Tyrosine Kinases/metabolism, Repressor Proteins/genetics, Repressor Proteins/metabolism, TNF Receptor-Associated Factor 1/genetics, TNF Receptor-Associated Factor 1/metabolism, Translocation, Genetic/genetics, Tumor Suppressor Protein p53/genetics, Tumor Suppressor Protein p53/metabolism

    وصف الملف: STAMPA; application/pdf

  16. 16
    Academic Journal